234 related articles for article (PubMed ID: 9152066)
1. Autoimmune retinopathy in the absence of cancer.
Mizener JB; Kimura AE; Adamus G; Thirkill CE; Goeken JA; Kardon RH
Am J Ophthalmol; 1997 May; 123(5):607-18. PubMed ID: 9152066
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration.
Heckenlively JR; Fawzi AA; Oversier J; Jordan BL; Aptsiauri N
Arch Ophthalmol; 2000 Nov; 118(11):1525-33. PubMed ID: 11074809
[TBL] [Abstract][Full Text] [Related]
3. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
[TBL] [Abstract][Full Text] [Related]
4. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated retinopathy vs recoverin-associated retinopathy.
Keltner JL; Thirkill CE
Am J Ophthalmol; 1998 Aug; 126(2):296-302. PubMed ID: 9727525
[No Abstract] [Full Text] [Related]
6. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
Huober J; Holz FG; Schmid H; Nölle B; Bellmann C; Krastel H; Wallwiener D; Bastert G
Zentralbl Gynakol; 1997; 119(6):278-81. PubMed ID: 9312964
[TBL] [Abstract][Full Text] [Related]
7. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
Guy J; Aptsiauri N
Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy.
Adamus G; Ren G; Weleber RG
BMC Ophthalmol; 2004 Jun; 4():5. PubMed ID: 15180904
[TBL] [Abstract][Full Text] [Related]
9. Immune-mediated retinopathy in a patient with stiff-man syndrome.
Steffen H; Menger N; Richter W; Nölle B; Krastel H; Stayer C; Kolling GH; Wässle H; Meinck HM
Graefes Arch Clin Exp Ophthalmol; 1999 Mar; 237(3):212-9. PubMed ID: 10090584
[TBL] [Abstract][Full Text] [Related]
10. Retinal degeneration under the effect of antibodies to recoverin.
Bazhin AV; Slepova OS; Tikhomirova NK
Bull Exp Biol Med; 2001 Apr; 131(4):350-2. PubMed ID: 11550024
[TBL] [Abstract][Full Text] [Related]
11. Presumed autoimmune retinopathy following chickenpox; a case report.
Prime Z; Sims J; Danesh-Meyer H
Int Ophthalmol; 2018 Oct; 38(5):2187-2190. PubMed ID: 28825165
[TBL] [Abstract][Full Text] [Related]
12. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
Adamus G; Machnicki M; Seigel GM
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
[TBL] [Abstract][Full Text] [Related]
14. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
[TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy.
Adamus G; Sugden B; Shiraga S; Timmers AM; Hauswirth WW
J Autoimmun; 2003 Sep; 21(2):121-9. PubMed ID: 12935781
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunologic aspects of cancer-associated retinopathy.
Ohguro H; Yokoi Y; Ohguro I; Mamiya K; Ishikawa F; Yamazaki H; Metoki T; Takano Y; Ito T; Nakazawa M
Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated retinopathy associated with invasive thymoma.
Katsuta H; Okada M; Nakauchi T; Takahashi Y; Yamao S; Uchida S
Am J Ophthalmol; 2002 Sep; 134(3):383-9. PubMed ID: 12208250
[TBL] [Abstract][Full Text] [Related]
18. The cancer-associated retinopathy antigen is a recoverin-like protein.
Thirkill CE; Tait RC; Tyler NK; Roth AM; Keltner JL
Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
[TBL] [Abstract][Full Text] [Related]
19. Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series.
Bourgault S; Baril C; Vincent A; Héon E; Ali A; MacDonald I; Lueder GT; Colleaux KM; Laliberté I
Br J Ophthalmol; 2015 Nov; 99(11):1536-42. PubMed ID: 25926518
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune retinopathy and antiretinal antibodies: a review.
Grewal DS; Fishman GA; Jampol LM
Retina; 2014 May; 34(5):827-45. PubMed ID: 24646664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
